Global GLP-1 Receptor Agonist Market By Product Type (Semaglutide, Liraglutide, Exenatide, Dulaglutide, and Others), By Route of Administration (Parenteral and Oral), By Application (Type 2 Diabetes Mellitus, Obesity, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during th...
